During the past decade, Ospedale Maurizio Bufalini conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Maurizio Bufalini" #1 sponsor was "AUSL Romagna Rimini" with 2 trials, followed by "Biotronik SE & Co. KG" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "Fadoi Foundation, Italy" with 1 trials sponsored and "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Maurizio Bufalini" #1 collaborator was "Royal Brompton & Harefield NHS Foundation Trust" with 2 trials as a collaborator, "A.O.U. Città della Salute e della Scienza - Molinette Hospital" with 1 trials as a collaborator, "Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia" with 1 trials as a collaborator, "Bambino Gesù Hospital and Research Institute" with 1 trials as a collaborator and "Biotronik SE & Co. KG" with 1 trials as a collaborator. Other collaborators include 94 different institutions and companies that were collaborators in the rest 104 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Maurizio Bufalini" are "ARDS, Human" (1 trials), "Acute Coronary Syndrome" (1 trials), "Anesthesia" (1 trials), "Aneurysmal Subarachnoid Hemorrhage" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Ospedale Maurizio Bufalini" in a lesser frequency.

Most popular intervention types in "Ospedale Maurizio Bufalini" are "Device" (3 trials), "Drug" (3 trials), "Procedure" (2 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Clazosentan" (1 trials), "Coronary Angioplasty (PTCA)" (1 trials), "Edoxaban" (1 trials), "Erector Spinae plane Block" (1 trials) and "General anesthesia + ESP block" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Maurizio Bufalini" are 11 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Maurizio Bufalini". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Ospedale Maurizio Bufalini, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Maurizio Bufalini, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".